Amsterdam Molecular Therapeutics B.V., Schering-Plough deal

Gene therapy company Amsterdam Molecular licensed IL-10 from SGP for use in developing an ex vivo gene therapy in inflammatory gastrointestinal diseases. Amsterdam Molecular also may develop IL-10 ex ...